Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027209
Status:
COMPLETED
Last Update Posted:
2006-05-15
First Post:
2001-11-28
Brief Title:
Hormone Replacement in Menopausal Women With Epilepsy
Sponsor:
National Institute of Neurological Disorders and Stroke NINDS
Organization:
National Institute of Neurological Disorders and Stroke NINDS
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2005-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to evaluate the effect of synthetic hormone replacement therapy on anti-seizure medication levels menopausal symptom relief and seizure frequency and safety in menopausal women with epilepsy
Detailed Description:
This study will help to answer questions regarding the use of hormone replacement therapy that women with epilepsy face as they reach menopause The total duration of the study is 6 months and involves 7 visits to the doctor The purposes of the study are to discover if and how menopause and treatments for the symptoms of menopause change epilepsy in women to determine which if any factors present before andor during menopause may predict the influence of menopause on a womans seizure disorder and to find any possible interactions between hormone replacement therapy and anti-seizure medication in order to find the optimal dose of hormone replacement therapy for women with epilepsy
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: